People_

Dr Matthew Parker

Clinical Senior Lecturer
Sydney Medical School
Central Clinical School
Faculty of Medicine and Health

Email

matthew.parker@sydney.edu.au

Resume

Dr Matthew Parker is a Staff Specialist and Head of the Department of Rheumatology at Royal Prince Alfred Hospital. He has a special clinical and research interest in autoimmune and related muscle diseases and in connective tissue disease-associated interstitial lung disease.

Awards and honours

New Investigator Award, Australian Rheumatology Association 2023

Brian Eaton Memorial PhD Scholarship, Lung Foundation Australia and Thoracic Society of Australia and New Zealand 2020-2023

The Leanne Stafford Scholarship, Australlian Rheumatology Association and Arthritis Australia 2017-2018

Publications

By Type

Expand all

Book Chapters

Parker, M., Bleasel, J. (2023). Hemophilia-associated arthritis. In Mark C. Hochberg (Eds.), Rheumatology 8th ed., (pp. 1840-1847). Philadelphia: Elsevier.
Parker, M. (2022). Skeletal Muscle and its Disorders. In Sean O'Neill, Lyn March, Leslie Schrieber, Terence Moopanar, Bill Walter (Eds.), The Musculoskeletal System Systems of the Body Series. Poland: Elsevier.
Parker, M., Chinoy, H., Cooper, R., Lamb, J. (2019). Myositis Basics/Who Gets Myositis. In Oddis CV and Aggarwal R Editors (Eds.), Managing Myositis: A Practical Guide, (pp. 7-15). Switzerland: Springer Books. [More Information]
Parker, M., McGill, N. (2019). The Established and Evolving Role of Nailfold Capillaroscopy in Connective-Tissue Disease. In Akira Takeda (Eds.), Connective Tissue Disease - Current State of the Art, (pp. 1-20). London: IntechOpen. [More Information]
Parker, M., Bleasel, J. (2017). Hemophilia and von Willebrand disease. In Hochberg MC (Eds.), Rheumatology (7th Ed.). London: Elsevier.

show 2 more

Journals

Parker, M., Jee, A., Hansen, D., Proudman, S., Youssef, P., Kenna, T., Stevens, W., Nikpour, M., Sahhar, J., Corte, T. (2024). Multiple serum biomarkers associate with mortality and interstitial lung disease progression in systemic sclerosis. Rheumatology, 63(11), 2981-2988. [More Information]
McColl, H., Cordina, R., Lal, S., Parker, M., Hunyor, I., Medi, C., Gray, B. (2024). Recurrent immunosuppressive-responsive myocarditis in a patient with desmoplakin cardio-myopathy: a case report. European Heart Journal - Case Reports, 8(3), ytae129. [More Information]
Parker, M., Lilleker, J., Chinoy, H. (2022). Adult idiopathic inflammatory myopathies. Medicine (United Kingdom), 50(1), 70-75. [More Information]
Jee, A., Parker, M., Bleasel, J., Troy, L., Lau, E., Jo, H., Teoh, A., Adelstein, S., Webster, S., Corte, T. (2021). Baseline Characteristics and Survival of an Australian Interstitial Pneumonia with Autoimmune Features Cohort. Respiration, 100(9), 853-864. [More Information]
Jee, A., Sheehy, R., Hopkins, P., Corte, T., Grainge, C., Troy, L., Symons, K., Spencer, L., Reynolds, P., Chapman, S., Jo, H., Bleasel, J., Parker, M., et al (2021). Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand*. Respirology, 26(1), 23-51. [More Information]
Jee, A., Parker, M., Bleasel, J., Troy, L., Lau, E., Jo, H., Teoh, A., Webster, S., Adelstein, S., Corte, T. (2021). Diagnosis of myositis-associated interstitial lung disease: Utility of the myositis autoantibody line immunoassay. Respiratory Medicine, 187, 106581. [More Information]
Sheikh, A., Parker, M., Gilbert, R., Chinoy, H. (2021). Focal hamstring muscle oedema and atrophy post-anterior cruciate ligament reconstruction mimicking focal myositis. Rheumatology, 60(2), 984-985. [More Information]
Jee, A., Parker, M., McGill, N., Bleasel, J., Webster, S., Troy, L., Corte, T. (2021). Nailfold capillaroscopy by smartphone-dermatoscope for connective tissue disease diagnosis in interstitial lung disease: A prospective observational study. ERJ Open Research, 7(4), 00416-2021. [More Information]
Loarce-Martos, J., Lilleker, J., Parker, M., McHugh, N., Chinoy, H. (2021). Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre. Rheumatology, 60(7), 3398-3403. [More Information]
Parker, M., Corte, T. (2020). First risk, next reward? A new clinico-radiological risk model predicts mortality in rheumatoid arthritis-associated interstitial lung disease. Respirology, 25(12), 1225-1226. [More Information]
To, F., Parker, M., Ventín-Rodríguez, C., Lilleker, J., Chinoy, H. (2019). Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria. Rheumatology, 58(12), 2331-2333. [More Information]
Parker, M., Oldroyd, A., Roberts, M., Lilleker, J., Betteridge, Z., McHugh, N., Herrick, A., Cooper, R., Chinoy, H. (2019). The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort. Rheumatology, 58(3), 468-475. [More Information]
Parker, M., Oliffe, M., McGill, N. (2018). An evaluation of two novel capillaroscopy techniques in suspected scleroderma-spectrum disorders: A single-centre cross-sectional study. Modern Rheumatology, 28(4), 676-680. [More Information]
Parker, M., Roberts, M., Lorigan, P., du Plessis, D., Chinoy, H. (2018). Autoimmune fasciitis triggered by the anti-programmed cell death-1 monoclonal antibody nivolumab. BMJ Case Reports, 2018, 223249. [More Information]
Parker, M., Lilleker, J., Roberts, M., Chinoy, H. (2018). Idiopathic inflammatory myopathies. Medicine (United Kingdom), 46(2), 140-145. [More Information]
Dey, A., Parker, M. (2018). Idiopathic inflammatory myopathies: when to suspect one and what to do about it. Medicine Today, 19(5), 33-39.
Parker, M., Oldroyd, A., Roberts, M., Ollier, W., New, R., Cooper, R., Chinoy, H., Ahmed, Y., Armstrong, R., Bernstein, R., et al (2018). Increasing incidence of adult idiopathic inflammatory myopathies in the City of Salford, UK: A 10-year epidemiological study. Rheumatology Advances in Practice, 2(2), 1-7. [More Information]
Parker, M., McGill, N. (2018). Minocycline-associated polyarteritis nodosa and self-limiting hepatitis: a reminder of a potentially re-emerging culprit in drug-induced autoimmune syndromes. Scandinavian Journal of Rheumatology, 47, 507-508. [More Information]
Parker, M., Chinoy, H. (2017). The Treatment Approach of Idiopathic Inflammatory Myopathies. European Medical Journal (Chelmsford, England), , 14-18. [More Information]
Parker, M., Khoo, L., Bleasel, J. (2016). Haemophilic arthropathy: can it be prevented? Medicine Today, 17(11), 55-60.
Parker, M., Guha, N., Stedman, B., Hacking, N., Wright, M. (2013). Trans-jugular intrahepatic porto-systemic shunt placement for refractory ascites: a 'real-world' UK health economic evaluation. Frontline Gastroenterology, 4(3), 182-186. [More Information]

show 18 more

By Year

Expand all

2024

Parker, M., Jee, A., Hansen, D., Proudman, S., Youssef, P., Kenna, T., Stevens, W., Nikpour, M., Sahhar, J., Corte, T. (2024). Multiple serum biomarkers associate with mortality and interstitial lung disease progression in systemic sclerosis. Rheumatology, 63(11), 2981-2988. [More Information]
McColl, H., Cordina, R., Lal, S., Parker, M., Hunyor, I., Medi, C., Gray, B. (2024). Recurrent immunosuppressive-responsive myocarditis in a patient with desmoplakin cardio-myopathy: a case report. European Heart Journal - Case Reports, 8(3), ytae129. [More Information]

2023

Parker, M., Bleasel, J. (2023). Hemophilia-associated arthritis. In Mark C. Hochberg (Eds.), Rheumatology 8th ed., (pp. 1840-1847). Philadelphia: Elsevier.

2022

Parker, M., Lilleker, J., Chinoy, H. (2022). Adult idiopathic inflammatory myopathies. Medicine (United Kingdom), 50(1), 70-75. [More Information]
Parker, M. (2022). Skeletal Muscle and its Disorders. In Sean O'Neill, Lyn March, Leslie Schrieber, Terence Moopanar, Bill Walter (Eds.), The Musculoskeletal System Systems of the Body Series. Poland: Elsevier.

2021

Jee, A., Parker, M., Bleasel, J., Troy, L., Lau, E., Jo, H., Teoh, A., Adelstein, S., Webster, S., Corte, T. (2021). Baseline Characteristics and Survival of an Australian Interstitial Pneumonia with Autoimmune Features Cohort. Respiration, 100(9), 853-864. [More Information]
Jee, A., Sheehy, R., Hopkins, P., Corte, T., Grainge, C., Troy, L., Symons, K., Spencer, L., Reynolds, P., Chapman, S., Jo, H., Bleasel, J., Parker, M., et al (2021). Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand*. Respirology, 26(1), 23-51. [More Information]
Jee, A., Parker, M., Bleasel, J., Troy, L., Lau, E., Jo, H., Teoh, A., Webster, S., Adelstein, S., Corte, T. (2021). Diagnosis of myositis-associated interstitial lung disease: Utility of the myositis autoantibody line immunoassay. Respiratory Medicine, 187, 106581. [More Information]
Sheikh, A., Parker, M., Gilbert, R., Chinoy, H. (2021). Focal hamstring muscle oedema and atrophy post-anterior cruciate ligament reconstruction mimicking focal myositis. Rheumatology, 60(2), 984-985. [More Information]
Jee, A., Parker, M., McGill, N., Bleasel, J., Webster, S., Troy, L., Corte, T. (2021). Nailfold capillaroscopy by smartphone-dermatoscope for connective tissue disease diagnosis in interstitial lung disease: A prospective observational study. ERJ Open Research, 7(4), 00416-2021. [More Information]
Loarce-Martos, J., Lilleker, J., Parker, M., McHugh, N., Chinoy, H. (2021). Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre. Rheumatology, 60(7), 3398-3403. [More Information]

show 3 more

2020

Parker, M., Corte, T. (2020). First risk, next reward? A new clinico-radiological risk model predicts mortality in rheumatoid arthritis-associated interstitial lung disease. Respirology, 25(12), 1225-1226. [More Information]

2019

To, F., Parker, M., Ventín-Rodríguez, C., Lilleker, J., Chinoy, H. (2019). Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria. Rheumatology, 58(12), 2331-2333. [More Information]
Parker, M., Chinoy, H., Cooper, R., Lamb, J. (2019). Myositis Basics/Who Gets Myositis. In Oddis CV and Aggarwal R Editors (Eds.), Managing Myositis: A Practical Guide, (pp. 7-15). Switzerland: Springer Books. [More Information]
Parker, M., McGill, N. (2019). The Established and Evolving Role of Nailfold Capillaroscopy in Connective-Tissue Disease. In Akira Takeda (Eds.), Connective Tissue Disease - Current State of the Art, (pp. 1-20). London: IntechOpen. [More Information]
Parker, M., Oldroyd, A., Roberts, M., Lilleker, J., Betteridge, Z., McHugh, N., Herrick, A., Cooper, R., Chinoy, H. (2019). The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort. Rheumatology, 58(3), 468-475. [More Information]

show 1 more

2018

Parker, M., Oliffe, M., McGill, N. (2018). An evaluation of two novel capillaroscopy techniques in suspected scleroderma-spectrum disorders: A single-centre cross-sectional study. Modern Rheumatology, 28(4), 676-680. [More Information]
Parker, M., Roberts, M., Lorigan, P., du Plessis, D., Chinoy, H. (2018). Autoimmune fasciitis triggered by the anti-programmed cell death-1 monoclonal antibody nivolumab. BMJ Case Reports, 2018, 223249. [More Information]
Parker, M., Lilleker, J., Roberts, M., Chinoy, H. (2018). Idiopathic inflammatory myopathies. Medicine (United Kingdom), 46(2), 140-145. [More Information]
Dey, A., Parker, M. (2018). Idiopathic inflammatory myopathies: when to suspect one and what to do about it. Medicine Today, 19(5), 33-39.
Parker, M., Oldroyd, A., Roberts, M., Ollier, W., New, R., Cooper, R., Chinoy, H., Ahmed, Y., Armstrong, R., Bernstein, R., et al (2018). Increasing incidence of adult idiopathic inflammatory myopathies in the City of Salford, UK: A 10-year epidemiological study. Rheumatology Advances in Practice, 2(2), 1-7. [More Information]
Parker, M., McGill, N. (2018). Minocycline-associated polyarteritis nodosa and self-limiting hepatitis: a reminder of a potentially re-emerging culprit in drug-induced autoimmune syndromes. Scandinavian Journal of Rheumatology, 47, 507-508. [More Information]

show 3 more

2017

Parker, M., Bleasel, J. (2017). Hemophilia and von Willebrand disease. In Hochberg MC (Eds.), Rheumatology (7th Ed.). London: Elsevier.
Parker, M., Chinoy, H. (2017). The Treatment Approach of Idiopathic Inflammatory Myopathies. European Medical Journal (Chelmsford, England), , 14-18. [More Information]

2016

Parker, M., Khoo, L., Bleasel, J. (2016). Haemophilic arthropathy: can it be prevented? Medicine Today, 17(11), 55-60.

2013

Parker, M., Guha, N., Stedman, B., Hacking, N., Wright, M. (2013). Trans-jugular intrahepatic porto-systemic shunt placement for refractory ascites: a 'real-world' UK health economic evaluation. Frontline Gastroenterology, 4(3), 182-186. [More Information]

Published abstracts:

Matthew JS Parker, Mandana Nikpour, Dylan Hanson, Susanna Proudman, Joanne Sahhar, Tamera J Corte, Tony J Kenna. High levels of Vascular Cell Adhesion Molecule 1 (VCAM-1) associate with a “vasculopathic phenotype” in systemic sclerosis with higher mortality. Oral Presentation ARA ASM 2024; Int J Rheum Dis e15171
Matthew JS Parker, Andre Chobanian, Ian Glaspole, Margaret Wilsher, Jeremy Wrobel, Yuben Moodley, et al. Myositis in the Australasian Interstitial Lung Disease Registry: an observational prospective cohort study of patients with idiopathic inflammatory myopa-thies complicated by interstitial lung disease. Oral Presentation ARA ASM 2024; Int J Rheum Dis e15171
Cameron E, Parker MJS. Evaluating a novel muscle biopsy technique: A retrospective case series of semi-open conchotome muscle biopsies in a quaternary myositis clinic. Poster Presentation ARA ASM 2024; Int J Rheum Dis e15172
Parker MJS, Beer K, Panicker A, Fong G, Needham M. The Australian Myositis Registry: the rationale, objectives and design of a multicentre nationwide longitudinal prospective data-base for patients with idiopathic inflammatory myopathies. Poster Presentation ARA ASM 2024; Int J Rheum Dis e15172
Li N, Frade S, Parker MJS, Youssef P, Nikpour M. Perspectives and Experiences regarding Exercise in Individuals with Myositis: A Qualitative study. Poster Presentation ARA ASM 2024; Int J Rheum Dis e15172
Parker MJS, Jee A, Hansen D et al. Serum biomarkers independently predict mortality in Systemic Sclerosis. Oral Presentation ARA ASM May 2023; Intern Med J 53(S1): 5-57 https://doi.org/10.1111/imj.16057
Parker MJS, Jee A, Hansen D et al. High levels of VCAM-1 independently predict mortality in Systemic Sclerosis. Oral Presentation TSANZ 2023. Respirol. 28(S2) 110-246 https://doi.org/10.1111/resp.14460
Jee A, Parker MJS, Corte T. Nailfold capillaroscopy findings using a smartphone-dermatoscope in a prospective Interstitial Lung Disease cohort. Oral presentation ARA ASM 2020. Int Med J. 50(S2):5-52 https://doi.org/10.1111/imj.14932
Loarce-Martos J, Lilleker JB, Parker MJS, Herrick A, McHugh NJ, Betteridge ZE, Chinoy H. Chipping away at polymyositis: a retrospective review at a tertiary myositis centre. EULAR 2020 Oral Abstract. Ann Rheum Dis 79(S1):1107
Jee A, Parker MJ, McGill NW, Bleasel JB, Troy, L, Jo H, Lau EM, Webster S, Geis M, Corte TJ. Nailfold Capillaroscopy in a prospective Interstitial Lung Disease Cohort: IPF, CTD-ILD and IPAF. American Thoracic Society 2019 Am J Respir Crit Care Med 2019; 199:A2416
Parker MJS, Oldroyd A, Lilleker JB, Roberts ME, New RP, Ollier WE, Cooper RG, Chinoy H. The increasing incidence of idiopathic inflammatory myopathies at a UK specialist neuro-muscular center: A ten-year epidemiological study. Oral Presentation British Society of Rheumatology May 2018. Rheumatology 2018;57(Suppl3):1-3.
Parker MJS, Oldroyd A, Lilleker JB, Roberts ME, Herrick AL, Cooper RG, Chinoy H. An ex-ternal validation of the 2017 EULAR/ACR Idiopathic Inflammatory Myopathies Classification Criteria. Oral Presentation, European League Against Rheumatism Annual Scientific Meeting, Amsterdam June 2018. ARD 2018;77(Suppl2) DOI: 10.1136/annrheumdis-2018-eular.6056
Parker MJS, Oldroyd A, Lilleker JB, Roberts ME, New RP, Ollier WE, Cooper RG, Chinoy H. The increasing incidence of idiopathic inflammatory myopathies at a UK specialist neuro-muscular center: A ten-year epidemiological study. Poster Presentation European League Against Rheumatism Annual Scientific Meeting June 2018. ARD 2018;77(Suppl2) DOI: 10.1136/annrheumdis-2018-eular.6079
Parker MJS, Oldroyd A, Lilleker JB, Roberts ME, New RP, Ollier WE, Cooper RG, Chinoy H. The increasing incidence of idiopathic inflammatory myopathies at a UK specialist neuro-muscular center: A ten-year epidemiological study. Poster presentation ARA ASM 2018. In-tern Med J 48(S4) https://doi.org/10.1111/imj.13772
Parker MJS, Oldroyd A, Lilleker JB, Roberts ME, Herrick AL, Cooper RG, Chinoy H. An ex-ternal validation of the 2017 EULAR/ACR Idiopathic Inflammatory Myopathies Classification Criteria. Poster Presentation ARA ASM 2018. Intern Med J 48(S4) https://doi.org/10.1111/imj.13772
Parker MJS, Oliffe MT, McGill NW. An evaluation of two novel techniques utilizing a smartphone digital camera in the assessment of nailfold capillaries in suspected Scleroder-ma-spectrum disorders: A single-center cross-sectional study. American College of Rheuma-tology Annual Scientific Meeting Nov 2017. Arthritis Rheum 2017;69 (Suppl10).

Page not found

Dr Matthew Parker

Publications

By Type

By Year